Analyzing the Latest N-PORT Filing for Q3 2024
Elfun Trusts (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2024, shedding light on its strategic investment decisions during this period. Elfun Trusts (Trades, Portfolio) is a fund exclusively available to General Electric's U.S. employees and trustees, forming part of the Elfun Funds alongside the Elfun International Equity Fund. Initially managed by David Carlson until 2019, the fund is now under the stewardship of William Sandow and Christopher Sierakowski. The fund's investment strategy focuses on U.S. companies, selecting equity securities from various industries based on individual company merits. The fund also considers companies with potential future dividend payouts, emphasizing stock selection as a key performance driver.
Summary of New Buy
Elfun Trusts (Trades, Portfolio) added a total of two stocks to its portfolio, with the most significant addition being Emerson Electric Co (EMR, Financial). The fund acquired 463,900 shares, which now account for 1.18% of the portfolio, with a total value of $50.74 million. The second largest addition was Abbott Laboratories (ABT, Financial), consisting of 419,700 shares, representing approximately 1.11% of the portfolio, with a total value of $47.85 million.
Key Position Increases
Elfun Trusts (Trades, Portfolio) increased its stakes in a total of nine stocks. The most notable increase was in Synopsys Inc (SNPS, Financial), with an additional 15,000 shares, bringing the total to 44,900 shares. This adjustment represents a significant 50.17% increase in share count, impacting the current portfolio by 0.18%, with a total value of $22.74 million. The second largest increase was in ASML Holding NV (ASML, Financial), with an additional 9,500 shares, bringing the total to 50,500. This adjustment represents a 23.17% increase in share count, with a total value of $42.08 million.
Summary of Sold Out
Elfun Trusts (Trades, Portfolio) completely exited one holding in the third quarter of 2024: Biomarin Pharmaceutical Inc (BMRN, Financial). The fund sold all 518,091 shares, resulting in a -1.02% impact on the portfolio.
Key Position Reduces
Elfun Trusts (Trades, Portfolio) reduced its position in 18 stocks, with the most significant changes including a reduction in UnitedHealth Group Inc (UNH, Financial) by 33,900 shares, resulting in a -16.86% decrease in shares and a -0.41% impact on the portfolio. The stock traded at an average price of $565.61 during the quarter and has returned -7.04% over the past three months and 6.25% year-to-date. Additionally, the fund reduced its position in S&P Global Inc (SPGI, Financial) by 32,800 shares, resulting in a -19.09% reduction in shares and a -0.35% impact on the portfolio. The stock traded at an average price of $494.89 during the quarter and has returned 1.59% over the past three months and 18.47% year-to-date.
Portfolio Overview
As of the third quarter of 2024, Elfun Trusts (Trades, Portfolio)' portfolio included 45 stocks. The top holdings were 8.37% in Microsoft Corp (MSFT, Financial), 8.18% in NVIDIA Corp (NVDA, Financial), 6.41% in Apple Inc (AAPL, Financial), 5.14% in Amazon.com Inc (AMZN, Financial), and 4.52% in Meta Platforms Inc (META, Financial).
The holdings are mainly concentrated in all 11 industries: Technology, Healthcare, Financial Services, Communication Services, Consumer Cyclical, Industrials, Energy, Consumer Defensive, Basic Materials, Utilities, and Real Estate.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
